NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









VivoSense

VivoSense

Private
CaliforniaHealthcare & Life Scienceshttps://www.vivosense.com/

Last Round

Series A

Mar 30, 2022

Total Funding Raised

$27.39M

Company Overview

VivoSense is a healthcare technology company that develops real-world digital clinical measures and provides end-to-end services for wearable sensor physiological monitoring in regulated clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Healthcare Analytics, Health IoT, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

digital clinical endpointswearable sensor datadigital biomarkersclinical trial softwarewearable sensor CROphysiological monitoringreal-world evidenceclinical research analyticsregulatory-grade dataremote patient monitoringRPMhealth IoTdata cleaningcontract research organizationCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VivoSense Comparables

Compare VivoSense with similar companies based on industry and business-model similarity.

VivoSense comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Koneksa Health
89%
BioSensics
81%
Ametris
81%

VivoSense Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 30, 2022
GrantOct 20, 2020
SeedSep 1, 2011

Key People

Founding team and executive leadership

Dudley Tabakin

Chief Product Officer, Chief Executive Officer

Executive Team

Doug McAllister

Chief Technology Officer

Executive Team

VivoSense Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 30, 2022

    $25M round led by Perceptive Advisors.

  • Oct 20, 2020

    $393K grant received from government agencies.

VivoSense Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VivoSense Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VivoSense's valuation, stock price, and market status.

Firmographic Details

HeadquartersCalifornia
Employee Range34
Year Founded2010
Last FundingMar 30, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.